Canada: New Litigation Shapes Fertility Obstetrical Malpractice Law

• Canadian law is actively developing to address malpractice in reproductive medicine and childbirth, a field where the duty of care remains largely undefined.
• A 2026 survey revealed that over a third of Canadian mothers experienced challenging or distressing labor, with higher rates among visible minority mothers.
• Leave to the Supreme Court of Canada for *Hemmings v. Peng* was denied, concluding the case's consideration by the highest court.
• Canada's *Assisted Human Reproduction Act* primarily focuses on criminal prohibitions but lacks operational standards, professional licensing for embryologists, and mandatory error reporting for fertility clinics.
• This regulatory gap in fertility services means major errors, such as embryo destruction or wrong-donor implantation, can occur repeatedly without centralized tracking or accountability.

The legal landscape surrounding reproductive medicine in Canada is actively evolving, grappling with complex questions of medical responsibility and patient rights in both obstetrics and fertility services.

The legal framework governing reproductive processes in Canada is currently undergoing significant development as new litigation emerges. Patients place immense trust in medical professionals during highly vulnerable periods, such as fertility treatments or childbirth. When this trust is compromised, whether through improper embryo handling, contraindicated medication, or the failure to disclose crucial options, Canadian law is actively working to define the scope of responsibility and appropriate compensation for affected individuals and their families.

A survey conducted by Neinstein LLP in February 2026 revealed that 34 percent of Canadian mothers described their labor experience as challenging or distressing, a figure that rose to 37 percent among visible minority mothers. These findings underscore a legal environment where the precise duty of care in reproductive medicine remains largely undefined. Rose Leto, a medical malpractice partner at Neinstein Personal Injury Lawyers in Toronto, frequently observes breaches related to oxytocin management in obstetric cases. She notes that Pitocin, a synthetic form of oxytocin used to augment labor, is a potent drug with strict administration guidelines. Deviations from these protocols, including disregarding maternal complaints or failing to investigate concerns, can lead to severe consequences for both mother and infant.

While a distressing experience alone does not constitute a legal claim, the established legal framework of breach, causation, and damages must still be satisfied. The Neinstein survey also indicated that 32 percent of mothers felt dismissed by medical staff, and 28 percent reported feeling pressured into decisions. This pattern aligns with observations from Leto's firm, which consistently finds that women lacking a support system or those from visible minority groups tend to experience poorer outcomes, a trend corroborated by their anecdotal evidence and the recent study.

A pivotal obstetric case, *Hemmings v. Peng*, for which leave to the Supreme Court of Canada was denied, highlights the complexities of medical responsibility in high-risk pregnancies. This case, argued by Neinstein LLP as co-counsel in February 2026, involves a patient with a high-risk pregnancy who was not presented with the option to terminate a pregnancy she did not wish to continue. Subsequently, she suffered a cardiac arrest during a caesarean section performed under anesthesia.

At the initial trial, the client was awarded $12 million in damages, a decision that was upheld by the Ontario Court of Appeal. However, this liability was assigned solely to the anesthesiologist involved. The central question that was to be examined by the Supreme Court was whether a physician who fails to inform a patient of their right to terminate a pregnancy should be held accountable for the profound injuries the patient later sustains. This case is poised to significantly influence the understanding of physician duties and liability in complex obstetric scenarios within Canadian birth injury litigation.

While obstetric malpractice operates within a comparatively more settled legal framework, negligence within fertility clinics presents a distinct set of challenges due to a significant regulatory void. According to Jan Marin, a senior lawyer at Gluckstein Lawyers in Toronto specializing in both birth injury and fertility negligence, the primary piece of legislation governing the fertility industry is the federal *Assisted Human Reproduction Act*. This act is largely criminal in nature, meaning breaches can lead to offenses and substantial penalties, particularly concerning prohibitions on the commercial sale of sperm, eggs, and surrogacy services.

However, the *Assisted Human Reproduction Act* notably fails to establish any operational standards for clinic practices. In Canada, embryologists, who are responsible for creating and handling biological materials, are not recognized as licensed professionals. Furthermore, there is no mandatory system for error reporting across any jurisdiction, leading to a critical lack of oversight. Marin emphasizes that the absence of tracking for major fertility errors means a single clinic could repeatedly experience serious incidents without any centralized system to connect these occurrences. She notes that she has handled multiple cases involving the same clinic, with errors ranging from accidental embryo destruction to the implantation of genetic material from the wrong donor, underscoring the systemic vulnerabilities in Canadian reproductive medicine malpractice.

The legal landscape surrounding reproductive medicine in Canada is actively evolving, grappling with complex questions of medical responsibility and patient rights in both obstetrics and fertility services. The *Hemmings v. Peng* case, for which leave to the Supreme Court of Canada was denied, was a critical development that could redefine the scope of physician accountability in obstetric care, particularly concerning patient autonomy and informed decision-making regarding pregnancy termination. Its outcome will undoubtedly shape future Canadian birth injury litigation.

Concurrently, the significant regulatory gaps in the fertility industry, as highlighted by the limitations of the *Assisted Human Reproduction Act*, present unique challenges for establishing accountability. The absence of operational standards, professional licensing for embryologists, and mandatory error reporting creates an environment where fertility clinic liability Canada is difficult to enforce consistently. This lack of centralized oversight means that patients undergoing reproductive medicine procedures may face heightened risks without adequate protective measures or clear avenues for redress. As such, the trajectory of Canadian fertility obstetrical malpractice law will continue to be shaped by both landmark court decisions and potential legislative efforts to address these critical regulatory shortcomings.

Lawyers advising on medical malpractice or personal injury should closely monitor developments in Canadian reproductive medicine litigation, particularly the outcomes of cases like Hemmings v. Peng and any legislative efforts to address the regulatory void in fertility clinic operations, as these will shape future liability and client claims.

Source: Original reporting via legal industry analysis.